Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient

被引:0
作者
Raju Dash
Md. Junaid
Sarmistha Mitra
Md Arifuzzaman
S. M. Zahid Hosen
机构
[1] Molecular Modeling and Drug Design Laboratory,Department of Anatomy
[2] Pharmacology Research Division,Department of Biochemistry and Biotechnology
[3] Bangladesh Council of Scientific and Industrial Research (BCSIR),Plasma Bioscience Research Center, Plasma
[4] Dongguk University Graduate School of Medicine,bio display
[5] University of Science and Technology Chittagong,Department of Natural Sciences, LAGCC
[6] Kwangwoon University,undefined
[7] City University of New York (CUNY),undefined
来源
Journal of Molecular Modeling | 2019年 / 25卷
关键词
VEGFR-2; Angiogenesis; Molecular docking; Molecular dynamics; MM-PBSA;
D O I
暂无
中图分类号
学科分类号
摘要
Vascular endothelial growth factor receptor-2 (VEGFR-2) is one of the regulatory elements of angiogenesis that is expressed highly in various diseases and is also essential for solid tumor growth. The present study was aimed at identifying potent inhibitors of VEGFR-2 by considering herbal secondary metabolites; as natural molecules are less toxic than synthetic derivatives. A structure-based virtual screening protocol consisting of molecular docking, MM-GBSA and ADME/T analysis was initially used to screen a library of in vivo metabolites of the herbal ingredient. Using a fixed cutoff value, four potent virtual hits were identified from molecular docking, ADME/T and binding affinity calculations, which were considered further for molecular dynamics (MD) simulation to broadly describe the binding mechanisms to VEGFR-2. The results suggested that these molecules have high affinity for the catalytic region of VEGFR-2, and form strong hydrophobic and polar interactions with the amino acids involved in the binding site of ATP and linker regions of the catalytic site. Subsequently, the stability of the docked complexes and binding mechanisms were evaluated by MD simulations, and the energy of binding was calculated through MM-PBSA analysis. The results uncovered two virtual hits, designated ZINC14762520 and ZINC36470466, as VEGFR-2 inhibitors, and suggested that they bind to kinase domain in an ATP-competitive manner. These virtual hits will offer a suitable starting point for the further design of their various analogs, allowing a rational search for more effective inhibitors in the future.
引用
收藏
相关论文
共 336 条
[1]  
Luo H(2008)Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids Nutr Cancer 60 800-809
[2]  
Jiang B-H(2001)Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation Lab Investig 81 1439-1451
[3]  
King SM(1992)Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 359 845-10
[4]  
Chen YC(2017)Molecular insight and binding pattern analysis of Shikonin as a potential VEGFR-2 inhibitor Curr Enzym Inhib 13 1-241
[5]  
Tsuzuki Y(2005)The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions Clin Sci 109 227-1177
[6]  
Carreira CM(2003)VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J Cell Biol 161 1163-128
[7]  
Bockhorn M(2017)In silico ADME/T and 3D QSAR analysis of KDR inhibitors J Appl Pharmaceut Sci 7 120-245
[8]  
Xu L(2010)Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway Mol Cancer 9 245-208
[9]  
Jain RK(2010)Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2 mAbs 2 199-745
[10]  
Fukumura D(2007)Molecular basis for sunitinib efficacy and future clinical development Nat Rev Drug Discov 6 734-1795